EX-FILING FEES 4 tm258820d2_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Tables

Form F-3 

(Form Type)

 

ProQR Therapeutics N.V.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

  Security
Type
Security
Class
Title
Fee
Calculation
or Carry
Forward
Rule
Amount
Registered (1) 
Proposed
Maximum
Offering
Price Per
Unit
Maximum
Aggregate
Offering
Price
Fee
Rate
Amount of
Registration 
Fee
Carry
Forward
Form
Type
Carry
Forward
File
Number
Carry
Forward
Initial
Effective
Date
Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
Newly Registered Securities

Fees to Be

 Paid

Equity

Ordinary Shares,
nominal value
€0.04 per
share (3)

457(c) 3,523,538 (2) $1.89 (3) $6,659,486.82 (3) $0.00015310 $1,019.57
Carry Forward Securities
Carry Forward Securities -— -—
  Total Offering Amounts   $6,659,486.82   $1,019.57        
                   
  Total Fees Previously Paid               
  Total Fee Offsets               
  Net Fee Due        $1,019.57        

 

(1)This Registration Statement on Form F-3 (this “Registration Statement”) also covers an indeterminate number of additional ordinary shares, nominal value €0.04 per share (“ordinary shares”), of ProQR Therapeutics N.V. (the “Registrant”), that may be offered or issued to prevent dilution resulting from share splits, share dividends or similar transactions in accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”).

 

(2)Represents the maximum number of ordinary shares that may be offered and sold, from time to time, by the selling shareholder named in the prospectus that forms a part of this Registration Statement (the “selling shareholder”), which ordinary shares were issued to the selling shareholder in a private placement.

 

(3)Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, and based upon the average of the high and low prices of ordinary shares, as reported on The Nasdaq Stock Market LLC, on March 10, 2025, a date within five business days prior to the filing of this Registration Statement.